EO2 Concepts is a San Antonio-based wound care company established in 2007. The company specializes in manufacturing a device that offers Continuous Diffusion of Oxygen (CDO) therapy, aimed at aiding the healing process for patients with challenging wounds. The CDO therapy has demonstrated success in treating a wide range of wounds, including diabetic foot ulcers, pressure ulcers, and venous stasis ulcers, among others.
With its last investment of $370.00K in a Seed Round on 18 November 2022, EO2 Concepts has garnered attention from investors. The investment provides the company with the means to further advance its technology and expand its market reach. Although the details of the investors behind this particular round are not specified, the injection of capital signifies a vote of confidence in the company's potential for growth and impact.
EO2 Concepts operates within the Biotechnology, Health Care, Manufacturing, and Pharmaceutical industries. With its headquarters in the United States, the company has been making strides in the medical field and contributing to the betterment of patient care. EO2 Concepts' dedication to advancing wound care through innovative oxygen therapy positions it at the forefront of the healthcare technology sector.
Connect with EO2 Concepts on social media platforms such as Facebook, Twitter, and Pinterest to stay updated on the latest developments and insights from the company.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Seed Round | $370.00K | - | 18 Nov 2022 | |
| Venture Round | $1.00M | - | 13 Jan 2021 | |
| Venture Round | $500.00K | - | 25 Aug 2020 | |
| Debt Financing | Unknown | - | 28 Aug 2019 | |
| Venture Round | $2.30M | - | 19 Aug 2019 |
No recent news or press coverage available for EO2 Concepts.
We care about your data, and we'd love to use cookies make your experience better.
